Cancer Letters
Volume 293, Issue 2 , Pages 189-197 , 28 July 2010

Extracellular ATP enhances in vitro invasion of prostate cancer cells by activating Rho GTPase and upregulating MMPs expression

  • Yang Zhang

      Affiliations

    • Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China
    • These authors contributed equally to this work.
    • ,
  • Li-hua Gong

      Affiliations

    • Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China
    • These authors contributed equally to this work.
    • ,
  • Hong-quan Zhang

      Affiliations

    • Departments of Histology and Embryology, Peking University Health Science Center, Beijing, China
    • ,
  • Qiang Du

      Affiliations

    • Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China
    • ,
  • Jiang-feng You

      Affiliations

    • Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China
    • ,
  • Xin-xia Tian

      Affiliations

    • Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China
    • Corresponding Author InformationCorresponding authors. Address: Department of Pathology, Peking University Health Science Center, 38 Xue Yuan Road, Beijing 100191, PR China. Tel.: +86 10 82802599; fax: +86 10 62015681.
    • ,
  • Wei-gang Fang

      Affiliations

    • Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China
    • Corresponding Author InformationCorresponding authors. Address: Department of Pathology, Peking University Health Science Center, 38 Xue Yuan Road, Beijing 100191, PR China. Tel.: +86 10 82802599; fax: +86 10 62015681.

Received 18 October 2009 ,Revised 4 January 2010 ,Accepted 11 January 2010.

References 

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA: Cancer J. Clin. 2009;59:225–249
  2. Denmeade SR, Isaacs JT. A history of prostate cancer treatment. Nat. Rev. Cancer. 2002;2:389–396
  3. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 2006;12:895–904
  4. Deli T, Csernoch L. Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors. Pathol. Oncol. Res. 2008;14:219–231
  5. Selzner N, Selzner M, Graf R, Ungethuem U, Fitz JG, Clavien PA. Water induces autocrine stimulation of tumor cell killing through ATP release and P2 receptor binding. Cell Death Differ. 2004;11(Suppl. 2):S172–S180
  6. Burnstock G. Potential therapeutic targets in the rapidly expanding field of purinergic signalling. Clin. Med. 2002;2:45–53
  7. Rapaport E. Experimental cancer therapy in mice by adenine nucleotides. Eur. J. Cancer Clin. Oncol. 1988;24:1491–1497
  8. Rapaport E, Fishman RF, Gercel C. Growth inhibition of human tumor cells in soft-agar cultures by treatment with low levels of adenosine 5′-triphosphate. Cancer Res. 1983;43:4402–4406
  9. Rapaport E. Treatment of human tumor cells with ADP or ATP yields arrest of growth in the S phase of the cell cycle. J. Cell Physiol. 1983;114:279–283
  10. Shabbir M, Thompson C, Jarmulowiczc M, Mikhailidis D, Burnstock G. Effect of extracellular ATP on the growth of hormone-refractory prostate cancer in vivo. Bju. Int. 2008;102:108–112
  11. Wang MX, Ren LM, Shan BE. Inhibitory effects of extracellular adenosine triphosphate on growth of esophageal carcinoma cells. World J. Gastroenterol. 2005;11:5915–5919
  12. Calvert RC, Shabbir M, Thompson CS, Mikhailidis DP, Morgan RJ, Burnstock G. Immunocytochemical and pharmacological characterisation of P2-purinoceptor-mediated cell growth and death in PC-3 hormone refractory prostate cancer cells. Anticancer Res. 2004;24:2853–2859
  13. Conigrave AD, van der Weyden L, Holt L, Jiang L, Wilson P, Christopherson RI, et al. Extracellular ATP-dependent suppression of proliferation and induction of differentiation of human HL-60 leukemia cells by distinct mechanisms. Biochem. Pharmacol. 2000;60:1585–1591
  14. Vandewalle B, Hornez L, Revillion F, Lefebvre J. Effect of extracellular ATP on breast tumor cell growth, implication of intracellular calcium. Cancer Lett. 1994;85:47–54
  15. Fang WG, Pirnia F, Bang YJ, Myers CE, Trepel JB. P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells. J. Clin. Invest. 1992;89:191–196
  16. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev. 2006;58:58–86
  17. Hatta Y, Takahashi M, Enomoto Y, Takahashi N, Sawada U, Horie T. Adenosine triphosphate (ATP) enhances the antitumor effect of etoposide (VP16) in lung cancer cells. Oncol. Rep. 2004;12:1139–1142
  18. Estrela JM, Obrador E, Navarro J, Lasso DLVM, Pellicer JA. Elimination of Ehrlich tumours by ATP-induced growth inhibition, glutathione depletion and X-rays. Nat. Med. 1995;1:84–88
  19. Chen L, He HY, Li HM, Zheng J, Heng WJ, You JF, et al. ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. Cancer Lett. 2004;215:239–247
  20. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987;47:3239–3245
  21. Takaoka K, Kishimoto H, Segawa E, Hashitani S, Zushi Y, Noguchi K, et al. Elevated cell migration, invasion and tumorigenicity in human KB carcinoma cells transfected with COX-2 cDNA. Int. J. Oncol. 2006;29:1095–1101
  22. Benard V, Bohl BP, Bokoch GM. Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases. J. Biol. Chem. 1999;274:13198–13204
  23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using Real-Time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408
  24. Heasman SJ, Ridley AJ. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat. Rev. Mol. Cell Biol. 2008;9:690–701
  25. White N, Burnstock G. P2 receptors and cancer. Trends Pharmacol. Sci. 2006;27:211–217
  26. Agteresch HJ, Burgers SA, van der Gaast A, Wilson JH, Dagnelie PC. Randomized clinical trial of adenosine 5′-triphosphate on tumor growth and survival in advanced lung cancer patients. Anticancer Drugs. 2003;14:639–644
  27. Leij-Halfwerk S, Agteresch HJ, Sijens PE, Dagnelie PC. Adenosine triphosphate infusion increases liver energy status in advanced lung cancer patients: an in vivo 31P magnetic resonance spectroscopy study. Hepatology. 2002;35:421–424
  28. Agteresch HJ, Dagnelie PC, van der Gaast A, Stijnen T, Wilson JH. Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer. J. Natl. Cancer Inst. 2000;92:321–328
  29. Agteresch HJ, Leij-Halfwerk S, Van Den Berg JW, Hordijk-Luijk CH, Wilson JH, Dagnelie PC. Effects of ATP infusion on glucose turnover and gluconeogenesis in patients with advanced non-small-cell lung cancer. Clin. Sci. (Lond). 2000;98:689–695
  30. Haskell CM, Mendoza E, Pisters KM, Fossella FV, Figlin RA. Phase II study of intravenous adenosine 5′-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancer. Invest. New Drugs. 1998;16:81–85
  31. Myrtek D, Idzko M. Chemotactic activity of extracellular nucleotides on human immune cells. Purinergic Signal. 2007;3:5–11
  32. La Sala A, Sebastiani S, Ferrari D, Di Virgilio F, Idzko M, Norgauer J, et al. Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes. Blood. 2002;99:1715–1722
  33. Verghese MW, Kneisler TB, Boucheron JA. P2U agonists induce chemotaxis and actin polymerization in human neutrophils and differentiated HL60 cells. J. Biol. Chem. 1996;271:15597–15601
  34. Mattila PK, Lappalainen P. Filopodia: molecular architecture and cellular functions. Nat. Rev. Mol. Cell. Biol. 2008;9:446–454
  35. Ellenbroek SI, Collard JG. Rho GTPases: functions and association with cancer. Clin. Exp. Metast. 2007;24:657–672
  36. Hall A. Rho GTPases and the control of cell behaviour. Biochem. Soc. Trans. 2005;33:891–895
  37. Aspenstrom P, Fransson A, Saras J. Rho GTPases have diverse effects on the organization of the actin filament system. Biochem. J. 2004;377:327–337
  38. Ellis S, Mellor H. The novel Rho-family GTPase rif regulates coordinated actin-based membrane rearrangements. Curr. Biol. 2000;10:1387–1390
  39. Chang SJ, Wang TY, Lee YH, Tai CJ. Extracellular ATP activates nuclear translocation of ERK1/2 leading to the induction of matrix metalloproteinases expression in human endometrial stromal cells. J. Endocrinol. 2007;193:393–404
  40. Robinson WR, Douillet CD, Milano PM, Boucher RC, Patterson C, Rich PB. ATP stimulates MMP-2 release from human aortic smooth muscle cells via JNK signaling pathway. Am. J. Physiol. Heart Circ. Physiol. 2006;290:H1988–1996
  41. Gu BJ, Wiley JS. Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor. Blood. 2006;107:4946–4953
  42. Decock J, Paridaens R, Cufer T. Proteases and metastasis: clinical relevance nowadays?. Curr. Opin. Oncol. 2005;17:545–550

PII: S0304-3835(10)00023-6

doi: 10.1016/j.canlet.2010.01.010

Cancer Letters
Volume 293, Issue 2 , Pages 189-197 , 28 July 2010

Article Tools

* Image Usage & Resolution